Dr. Singh is actively licensed board certified in internal medicine. He is currently the CEO of gWell, Inc, a genomics and wellness focused digital health company, and serves as a senior advisor and board member for mission aligned companies and non-profits. In addition, he is an Adjunct Instructor of Medicine at Harvard Medical School. He was formerly Corporate Vice-President and Chief Medical Officer of Specialty Pharmacy at CVS Health, and was an attending physician for many years at the Brigham and Women’s Hospital in Boston.
MD: Johns Hopkins University School of Medicine
BS: University of Texas at Austin
American Board of Internal Medicine
Videos
I think genomics, along with epigenomics or how genes are expressed and turned on or off, as well as proteomics, how the entire spectrum of proteins that are produced by cells interact with each other...
Watch and ShareVideos
“In 10 years, I expect that gene and cellular therapies will have proliferated, hopefully much more than we can currently conceive. I think there’ll be dozens of different gene therapies and even more than one...
Watch and ShareVideos
“For several decades, even centuries, people have thought through the ramifications of being able to modify genetic material, in essence, to be able to have “”designer babies.”” Gene therapy is nothing of this sort. Gene...
Watch and ShareVideos
So the durability or how long gene therapies will last is one of the biggest questions facing this new class of treatment. Unfortunately, the answer is complicated. We don’t yet know how long even the...
Watch and ShareVideos
“So CAR-T cell treatments are one of the newest approaches to cancer treatment. It’s a part of a field and a movement called immunooncology. Essentially we’re using immune system cells from the patient themselves and...
Watch and ShareVideos
“So we all know that there are families where cancer is much more prevalent. Basically we say that cancer runs in those families, and we know that there’s a hereditary component that’s passed from one...
Watch and ShareVideos
“The second big area is the ethical question and dilemma of how to get these treatments, these life-saving treatments, to patients across the globe. But the cost of the most recently launched gene therapy in...
Watch and ShareVideos
I think that tumor genomics will be routinely used in structuring the treatment plan for patients early in the process. Basically, at the time that a particular tumor is detected, the tumor specimen will be...
Watch and ShareVideos
First, in 10 years, I see the proliferation of tools that allow for these technologies to be used in much more practical ways, by both patients and clinicians will have vastly improved. They should be...
Watch and ShareVideos
Gene therapy is under rigorous evaluation by researchers, developers, regulators, and other officials all converging to try to understand all the different aspects of safety when you inject DNA material into cells. This was the...
Watch and Share
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
